Last reviewed · How we verify
Mylan's insulin glargine
Mylan's insulin glargine is a Insulin analog Small molecule drug developed by Mylan Inc.. It is currently in Phase 3 development for Type 2 diabetes, Type 1 diabetes.
Insulin glargine is a long-acting insulin analog that mimics the action of human insulin to lower blood glucose levels.
Insulin glargine is a long-acting insulin analog that mimics the action of human insulin to lower blood glucose levels. Used for Type 2 diabetes, Type 1 diabetes.
At a glance
| Generic name | Mylan's insulin glargine |
|---|---|
| Sponsor | Mylan Inc. |
| Drug class | Insulin analog |
| Target | Insulin receptor |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
It works by stimulating glucose uptake in cells, inhibiting glucose production in the liver, and slowing gastric emptying. This results in a sustained decrease in blood glucose levels over a 24-hour period.
Approved indications
- Type 2 diabetes
- Type 1 diabetes
Common side effects
- Hypoglycemia
- Weight gain
- Allergic reactions
Key clinical trials
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1) (PHASE3)
- Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) Patients (PHASE3)
- Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 2 Diabetes Mellitus Patients (INSTRIDE 2) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mylan's insulin glargine CI brief — competitive landscape report
- Mylan's insulin glargine updates RSS · CI watch RSS
- Mylan Inc. portfolio CI
Frequently asked questions about Mylan's insulin glargine
What is Mylan's insulin glargine?
How does Mylan's insulin glargine work?
What is Mylan's insulin glargine used for?
Who makes Mylan's insulin glargine?
What drug class is Mylan's insulin glargine in?
What development phase is Mylan's insulin glargine in?
What are the side effects of Mylan's insulin glargine?
What does Mylan's insulin glargine target?
Related
- Drug class: All Insulin analog drugs
- Target: All drugs targeting Insulin receptor
- Manufacturer: Mylan Inc. — full pipeline
- Therapeutic area: All drugs in Diabetes
- Indication: Drugs for Type 2 diabetes
- Indication: Drugs for Type 1 diabetes
- Compare: Mylan's insulin glargine vs similar drugs
- Pricing: Mylan's insulin glargine cost, discount & access